Renal transporter OAT1 and PPAR ‐α pathway co‐contribute to icaritin‐induced nephrotoxicity
Phytotherapy Research · 2023-02 · 37 (2) · 549-562
DOI: 10.1002/ptr.7633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 04.11.2022. Verfasst von Dalong Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Peroxisome Proliferator-Activated Receptors, Proteomics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
This study aimed to investigate the potential nephrotoxicity of icaritin and the underlying mechanism by in vitro – in vivo experiment technology combined with proteomics technology. First, icaritin showed a significant cytotoxic effect on HK‐2 cells, which was accompanied by increased LDH and TNF‐α in the supernatant, decreased protein expressions of Bcl‐2 and increased Bax and enhanced apoptosis of HK‐2 cells as measured by TUNEL staining. Moreover, icaritin induced obvious tubular damage and up‐regulation of BUN and CRE levels in plasma in mice. Second, intracellular uptake of icaritin was considerably higher in hOAT1‐HEK293 cells than in mock‐HEK293 cells, suggesting that icaritin might accumulate in renal cells via OAT1 uptake. Importantly, icaritin caused significant changes in the PPAR signaling pathway in HK2 cells through proteomic analysis. Then, in vitro and in vivo results verified that icaritin significantly downregulated the protein expression of PPAR‐α as well as downregulated APOB, ACSL3, ACSL4, and upregulated 5/12/15‐HETE, implying that a lipid metabolism disorder was involved in the icaritin‐induced nephrotoxicity. Finally, icaritin was found to increase the accumulation of iron and LPO levels while reducing the activity of GPX4, suggesting that ferroptosis was involved in the nephrotoxicity induced by icaritin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Dalian Medical University, Dalian, China.
- Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning Dalian Medical University, Dalian, China.
- School of Chemistry and Materials Science, University of Science and Technology of China, Hefei, China.
- Key Laboratory of Separation Sciences for Analytical Chemistry, Chinese Academy of Sciences, Dalian, China.
ORCID-Profile: Qiang Meng, Huijun Sun, Jingjing Wu
Förderung
- Liaoning Revitalization Talents Program
- National Natural Science Foundation of China
Zitieren
APA
Wang, D., Liu, J., Chen, X., Chen, J., Zhao, T., Du, J., Wang, C., Meng, Q., Sun, H., Wang, F., Liu, K., & Wu, J. (2023). Renal transporter OAT1 and PPAR ‐α pathway co‐contribute to icaritin‐induced nephrotoxicity. Phytotherapy Research, 37(2), 549-562. https://doi.org/10.1002/ptr.7633
Vancouver
Wang D, Liu J, Chen X, Chen J, Zhao T, Du J, et al. Renal transporter OAT1 and PPAR ‐α pathway co‐contribute to icaritin‐induced nephrotoxicity. Phytotherapy Research. 2023;37(2):549-562. doi:10.1002/ptr.7633
BibTeX
@article{Wang2023,
author = {Wang, Dalong and Liu, Jing and Chen, Xiaodong and Chen, Jing and Zhao, Tingting and Du, Jie and Wang, Changyuan and Meng, Qiang and Sun, Huijun and Wang, Fangjun and Liu, Kexin and Wu, Jingjing},
title = {Renal transporter OAT1 and PPAR ‐α pathway co‐contribute to icaritin‐induced nephrotoxicity},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {2},
pages = {549--562},
doi = {10.1002/ptr.7633}
}
EUVIMED